CeleCor Therapeutics Competitors and Similar CompaniesClear all

CeleCor Therapeutics's competitors and similar companies include Tridek-One, InProcess-LSP and ExtremoChem.
CeleCor Therapeutics
CeleCor Therapeutics
CeleCor Therapeutics is a company that provides a solution supporting the treatment of serious heart attacks.
Tridek-One
Tridek-One
Tridek-One is a biopharmaceutical company that develops products for treatment of immuno-inflammatory diseases.
InProcess-LSP
InProcess-LSP
InProcess-LSP is a company that offers analytical services and solutions for pharma, food, life sciences to support product and process development, and manufacturing.
ExtremoChem
ExtremoChem
ExtremoChem is a company that develops and commercializes small synthetic molecules for the stabilization of biologicals.
Founding Date
Founding Date
N/A
Founding Date
2018
Founding Date
2014
Founding Date
2013
Type
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Del Mar, US HQ
Locations
Paris, FR HQ
Locations
Oss, NL HQ
Oss, NL
Locations
Lisboa, PT HQ
Employees
Employees
5
Employees
14
Employees
20
Employees
5

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 81.7k (over 7 years ago)
Latest funding round
$ 53.1k (over 9 years ago)
Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 81.7k
Total funding raised
$ 53.1k
For sources of this data, please see the company profile

View Company Profiles

Tridek-One
HQ
Paris, FR
Employees
14

Tridek-One is a biopharmaceutical company that develops products for treatment of immuno-inflammatory diseases.

View company
InProcess-LSP
HQ
Oss, NL
Employees
20

InProcess-LSP is a company that offers analytical services and solutions for pharma, food, life sciences to support product and process development, and manufacturing.

View company
ExtremoChem
HQ
Lisboa, PT
Employees
5

ExtremoChem is a company that develops and commercializes small synthetic molecules for the stabilization of biologicals.

View company